Detalhe da pesquisa
1.
Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center.
Leuk Lymphoma
; 64(5): 1050-1053, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891585